American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$493M |
| 2 |
Colgate-Palmolive
CL
|
+$367M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Fidelity National Information Services
FIS
|
+$298M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$300M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$268M |
| 3 |
Medtronic
MDT
|
+$233M |
| 4 |
Intercontinental Exchange
ICE
|
+$201M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.66% |
| 2 | Technology | 16% |
| 3 | Healthcare | 15% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
GDS Holdings
GDS
$6.45B
| $281M | 0.28% |
7,007,209
+652,475
| +10% | +$26.3M |
|
102
HDFC Bank
HDB
$119B
| $277M | 0.28% |
9,722,676
+74,208
| +0.8% | +$2.11M |
|
103
Southwest Airlines
LUV
$21.9B
| $276M | 0.28% |
5,117,803
-159,768
| -3% | -$8.36M |
|
104
Baker Hughes
BKR
$64.3B
| $274M | 0.28% |
11,830,530
+2,787,184
| +31% | +$65.4M |
|
105
Monster Beverage
MNST
$89.2B
| $273M | 0.27% |
18,811,144
-80,480
| -0.4% | -$1.22M |
|
106
Ameriprise Financial
AMP
$49.4B
| $270M | 0.27% |
1,834,674
+1,106
| +0.1% | +$155K |
|
107
ONE Gas
OGS
$5B
| $270M | 0.27% |
2,807,501
-53,379
| -2% | -$4.87M |
|
108
Eversource Energy
ES
$26.7B
| $269M | 0.27% |
3,149,462
-1,642,920
| -34% | -$131M |
|
109
MSC Industrial Direct
MSM
$6.58B
| $265M | 0.27% |
3,659,933
+515,682
| +16% | +$36.1M |
|
110
Genuine Parts
GPC
$18.3B
| $265M | 0.27% |
2,660,594
+965,196
| +57% | +$92.6M |
|
|
BNY
111
Bank of New York Mellon
BNY
$111B
| $264M | 0.27% |
5,850,089
-2,326,409
| -28% | -$104M |
|
112
EOG Resources
EOG
$74.6B
| $263M | 0.26% |
3,539,180
-827,293
| -19% | -$67M |
|
113
Regeneron Pharmaceuticals
REGN
$81.8B
| $262M | 0.26% |
943,920
-88,094
| -9% | -$26.1M |
|
114
Roper Technologies
ROP
$38.7B
| $261M | 0.26% |
732,723
-211,408
| -22% | -$76.8M |
|
115
Take-Two Interactive
TTWO
$45.3B
| $256M | 0.26% |
2,038,934
+50,318
| +3% | +$6.28M |
|
116
Aflac
AFL
$60.4B
| $251M | 0.25% |
4,792,646
-2,688,628
| -36% | -$142M |
|
117
Stryker
SYK
$132B
| $248M | 0.25% |
1,147,920
+108,090
| +10% | +$23.2M |
|
118
Elanco Animal Health
ELAN
$11B
| $243M | 0.24% |
9,120,261
+1,349,274
| +17% | +$40.5M |
|
119
Bio-Rad Laboratories Class A
BIO
$9.43B
| $242M | 0.24% |
727,542
-21,260
| -3% | -$6.94M |
|
120
Verisk Analytics
VRSK
$23.4B
| $242M | 0.24% |
1,530,655
+282,418
| +23% | +$43.8M |
|
121
Berkshire Hathaway Class B
BRK.B
$1.09T
| $242M | 0.24% |
1,162,012
+369,831
| +47% | +$76.2M |
|
122
Booz Allen Hamilton
BAH
$9.25B
| $241M | 0.24% |
3,386,471
-627,736
| -16% | -$44.4M |
|
123
Burlington
BURL
$22.2B
| $240M | 0.24% |
1,201,576
-858,968
| -42% | -$158M |
|
|
TWTR
124
DELISTED
Twitter, Inc.
TWTR
| $239M | 0.24% |
5,811,659
+519,506
| +10% | +$21.2M |
|
125
CoStar Group
CSGP
$12.4B
| $238M | 0.24% |
4,014,960
-1,257,270
| -24% | -$75.3M |
|
Similar funds
American Century Companies's Q3 2019 Portfolio in Review
As of Q3 2019, American Century Companies held 1,407 positions worth $99.6B, down 0.83% from $100B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
American Century Companies's Q3 2019 filing shows 144 new, 546 increased, 497 reduced and 204 closed positions. Its largest new stake was A.O. Smith: 2,750,567 shares worth $131M. The largest sale was Worldpay, Inc., an estimated $300M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- American Century Companies's largest Q3 2019 buy was A.O. Smith: 2,750,567 shares worth $131M.
- American Century Companies added most to Pfizer in Q3 2019, an estimated $493M increase.
- American Century Companies's biggest Q3 2019 reduction was Medtronic, cutting an estimated $233M.
- American Century Companies fully exited Worldpay, Inc. in Q3 2019, selling an estimated $300M.
- American Century Companies's ten largest holdings make up 18% of its $99.6B portfolio in Q3 2019.
- American Century Companies opened 144 new positions and closed 204 in Q3 2019.
- American Century Companies's portfolio value fell 0.83% quarter-over-quarter to $99.6B.
Based on American Century Companies's 13F filing for Q3 2019, filed 13 Nov 2019.